m

J&J names spinoff consumer health business

Johnson & Johnson's consumer health business, which will break away from its pharmaceutical and medical device arm, will be named Kenvue, the company said Sept. 28. 

The New Brunswick, N.J.-based drugmaker first announced the split into two independent companies in November 2021. This year, J&J tapped Thibaut Mongon as the consumer health company's CEO and Larry Merlo, the former president and CEO of CVS, as a chairman. 

The name "is inspired by two powerful ideas: 'ken' — meaning knowledge, an English word primarily used in Scotland, and 'vue,' referencing sight," according to J&J. 

Last year, J&J's consumer health business — which makes brands including Band-Aid, Tylenol, Neutrogena and Listerine — accumulated $14.6 billion in revenue. Its pharmaceutical division made $52 billion and its medical device side made $27 billion. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like